Detection methods and clinical applications of circulating tumor cells in breast cancer

doi:10.3877/cma.j.issn.2095-5820.2017.02.004

Abstract

Abstract:

Early metastasis of breast cancer and recurrence is proved to be the greatest threat to the patients. The detection of circulating breast tumor cells in blood is an important evidence of tumor micrometastasis. Current detection methods of circulating tumor cells including antibody based technique, nucleic acid based technique and the joint detection methods. All of them have their advantages and limitations.

Key words: Circulating tumor cells, Breast cancer, Micrometastasis

Yujie Wang, Xia Guo, Xiaofei Wang. Detection methods and clinical applications of circulating tumor cells in breast cancer[J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2017, 05(02): 78-80.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcsysgldzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-5820.2017.02.004

https://zhlcsysgldzzz.cma-cmc.com.cn/EN/Y2017/V05/I02/78

References 21

1	Husemann Y, Geigl JB, Schubert F, et al. Systemic spread is an early step in breast cancer[J]. Cancer Cell, 2008,13(1):58-68.
2	Hu XC, Loo WT, Chow LW. Surgery-related shedding of breast cancer cells as determined by RT-PCR assay[J]. J Surg Oncol, 2003,82(4):228-233.
3	Ismail MS, Wynendaele W, Aerts JL, et al. Detection of micrometastatic disease and monitoring of perioperative tumor cell dissemination in primary operable breast cancer patients using real-time quantitative reverse transcription-PCR[J]. Clin Cancer Res, 2004,10:196-201.
4	Biggers B, Knox S, Grant M, et al. Circulating tumor cells in patients undergoing surgery for primary breast cancer:preliminary results of a pilot study[J].Ann Surg Oncol, 2009,16(4):969-971.
5	Gilbey AM, Burnett D, Coleman RE, et al. The detection of circulating cancer cells in blood[J]. J Clin Pathol, 2004,57(5):903-908.
6	Mostert B, Sleijfer S, Foekens JA, et al. Circulating tumor cells (CTCs):detection methods and their clinical relevance in breast cancer[J]. Cancer Treat Rev, 2009,35(5):463-474
7	Hou JM, Krebs MG, Iancashire L, et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboil in patients with small-cell lung cancer[J]. J Clin Oncol, 2012,30(2):525-532.
8	Linuma H, Watanabe T, Mimori K, et al. Clinical significance of circulating tumor cells, including cancer stem-like cells, inperpheral blood for recurrence and prognosis in patients with Dukes′ stage B and C colorectal cancer[J]. J Clin Oncol, 2011,29(2):1547-1555.
9	李蕾，江泽飞. 循环肿瘤细胞检测在不同阶段、不同类型乳腺癌中的应用[J]. 中国癌症杂志, 2013,23(8):570-575.
10	Riethdorf S, Muller V, Zhang L, et al. Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant Gepar Quattro trial[J]. Clin Cancer Res, 2010,16(9):2634-2645.
11	Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression,and survival in metastatic breast cancer[J]. N Engl J Med, 2004,351(8):781-791.
12	Jiang ZF, Cristofanilli M, Shao ZM, et al. Circulating tumor cells predict progression-free and overallsurvival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): a multicenter,double-blind, prospective trial[J]. Ann Oncol, 2013,24(11):2766-2772.
13	Tewes M, Aktas B, Welt A, et a1. Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast concer：an option for monitoring response to breast cancer related therapies[J]. Breast Concer Res Treat, 2009,115(3):581-90.
14	李蕾，刘毅，张少华, 等. 循环肿瘤细胞检测在不同阶段、不同类型乳腺癌中的应用及意义[J]. 中华医学杂志, 2014,94(36):2812-2815.
15	Smerage JB, Hayes DF, Doyle GV, et a1. Assessment of circulating tumor cells in breast callcer patients undergoing neoadjuvant chemotherapy[J]. J Clin Oncol, 2006, 24(18S):1079-1085．
16	Camara O, Rengsberger M, Egbe A, et aI. The relevance of circulating epithelial tumor cells(CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer[J]. Ann Oncol, 2007,18(9):1484-1492．
17	Fehm T, Sagalowsky A, Clifford E, et a1. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant[J]. Clin Cancer Res, 2002,8(7):2073-2084.
18	Pogue-Geile KL, Kim C, Jeong JH, et al. Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31[J]. J Natl Cancer Inst, 2013,105:1782-1788.
19	Meng SD, Tripathy D, Shete S, et a1. HER-2 gene amplification can be acquired as breast cancer progresses[J]. Proc Natl Acad Sci, 2004,101(25):9393-9398.
20	Wulfing P, Borchard J, Buerger H, et a1. HER2-Positive circulating tumor cells indicate poor clinical outcome in stage I to Ⅲ breast callcer patients[J]. Clin Cancer Res, 2006,12(6):1715-1720.
21	Reuben JM, Lee BN, Broglio KR, et a1. Genomic of circulating tumor cells in inmetastatic breast cancer[J]. J Clin Oncol, 2007,25(18S):1002.

[1]	Xu Zhang, Jianping Xu, Dongming Su, Caifen Wang, Dali Wang, Wenzhi Zhang. Contrast-enhanced ultrasound features of male breast masses [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 854-859.
[2]	Hua Shao, Ziyue Na, Hui Jing, Bo Li, Qiucheng Wang, Wen Cheng. Value of preoperative percutaneous contrast-enhanced ultrasound in diagnosis of axillary sentinel lymph node metastasis and burden in breast cancer [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 849-853.
[3]	Meiwu Zhang, Shuyi Lyu, Xiaoxiang Fan, Luhui Zhuang, Yuqin Qiu, Baisong Zhang, Yan Zhang. Clinical value of ultrasound-guided aspiration combined with hypertonic glucose flushing in treatment of postoperative subcutaneous effusion in patients with breast cancer [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(03): 327-331.
[4]	Hua Zhang, Yu Sun, Shijian Xiang, Yingmei Li, Xiaoqun Wang. Research on chemosensitivity evaluation using circulating tumor cells in advanced gastrointestinal cancer [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 422-425.
[5]	Xueyuan Feng, Mengmeng Han, Ning Ma. Detection of circulating tumor cells and its application in breast cancer [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(03): 231-236.
[6]	bing Feng, Qiuguo Zou, Zhenbo Liang, Yanming Lu, Yi Zeng, Shumiao Wu. Clinical study of ultrasonic signs and molecular biological indicators of senile non-specific invasive breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 48-51.
[7]	Yansong Li, Huimin Feng, Mingchao Liu, Zepeng Liu, Qiuxia Jiang. Expression and clinical significance of STIP1 in triple negative breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 52-56.
[8]	Jia Wang, Baoliang Guo, Shan Wang, Dianlong Zhang, Mijia Wang, Tianyang Zhou, Jianguo Zhang, Feng Jin. Interpretation of clinical practice guidelines for diagnosis and treatment of de novo stage Ⅳ breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(03): 250-254.
[9]	Yating Wu, Shenghang Zhang, Shuiliang Wang. Research progress in the role of dysregulated RNA m⁶A modification in breast cancer metastasis [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(01): 45-52.
[10]	Ruixue Yue, Lingxin Kong, Xin Hao, Jinqiang Yang, Meng Han, Guozhong Cui, Jianjun Wang, Zhisheng Zhang, Fanting Kong, Wei Zhang, Wenbo He, Xianqiao Li, Xinping Zhou, Donghong Xu, Chongzhu Hu. HER2 protein expression levels predict efficacy of neoadjuvant therapy in breast cancer: A real-world study [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(07): 765-770.
[11]	Fei Liu, Yingxin Wang, Xing Ma, Ling Xin, Yuanjia Cheng, Qian Liu, Yue Wang, Junjun Zhang. Different conductive media for intracavitary electrocardiogram-guided arm port implantation among breast cancer patients: a randomized controlled trial [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(07): 760-764.
[12]	Jiayi Li, Hong Zhang, Jingming Ye, Yinhua Liu, Ling Xu, Shuang Zhang. Androgen receptor: discoveries in breast cancer clinical practice [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(11): 1031-1038.
[13]	Junwei Cui, Yinhua Liu, Xiaoling Liu, Yibing Hu, Hui Hu. Efficacy and safety of trastuzumab and pertuzumab combined with chemotherapy in neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(11): 1062-1067.
[14]	Exian Mou, Hao Wang, Li Xia, Juan Li, Shiyan Zeng, Miao Yu, Junjie Li, Jia Xu, Purong Zhang, Man Lu, Hui Li, Shiwei Liu. Contrast-enhanced ultrasonography combined with blue dye for sentinel lymph node biopsy in neoadjuvant-treated HER2-positive or triple-negative breast cancer with initially biopsy-proven nodal metastasis [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(11): 1068-1074.
[15]	Zeyu Cai, Huimin Lan, Ting Yu, Hui Luo. The study based on Ti₃C₂ loaded with doxorubicin and combined with photothermal therapy for inhibiting the proliferation of breast cancer cells [J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2023, 11(02): 140-145.

Please choose a citation manager

Content to export